Aerovate Therapeutics
AVTE
#9175
Rank
S$0.10 B
Marketcap
$3.52
Share price
-0.37%
Change (1 day)
-89.07%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$5.12 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are S$5.12 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$23.72 M106.77%
2022-12-31S$11.47 M188.16%
2021-12-31S$3.98 M-83.34%
2020-12-31S$23.89 M147.6%
2019-12-31S$9.64 M